Dose-response relationships for human tumors: Implications for clinical trials of dose modifying agents (Q72825368)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6237084%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

title

Dose-response relationships for human tumors: implications for clinical trials of dose modifying agents (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6237084%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

Dose-response relationships for human tumors: Implications for clinical trials of dose modifying agents (English)

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90532-7

radiation dose-response relationship

4 September 2023

main subject

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6237084

4 September 2023

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90532-7

4 September 2023

author name string

M. V. Williams

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6237084

4 September 2023

J. Denekamp

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6237084

4 September 2023

J. F. Fowler

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6237084

4 September 2023

language of work or name

English

0 references

publication date

1 September 1984

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6237084%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

29 October 2019

https://api.elsevier.com/content/article/PII:0360301684905327?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90532-7

https://api.elsevier.com/content/article/PII:0360301684905327?httpAccept=text/plain

4 September 2023

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90532-7

International Journal of Radiation Oncology Biology Physics

4 September 2023

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6237084%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6237084%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6237084%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

page(s)

1703-1707

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6237084%20AND%20SRC:MED&resulttype=core&format=json

The dose—time relationship in the radiotherapy of carcinoma of the cervix uteri: An application of the CRE formalism

29 October 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90532-7

Results of radical radiotherapeutic treatment of carcinoma of the pyriform sinus: experience of the Institut Curie

4 September 2023

3

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90532-7

Relation between time-dose and local control of operable breast cancer treated by tumorectomy and radiotherapy or by radical radiotherapy alone

4 September 2023

4

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90532-7

Nitroakridin 3582: a fluorescent nitroacridine stain for identifying hypoxic cells

4 September 2023

5

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90532-7

The number of patients required in a clinical trial

4 September 2023

6

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90532-7

Carcinoma of the Cervix Treated by External Irradiation Alone

4 September 2023

7

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90532-7

First results of a randomized clinical trial of fast neutrons compared with X or gamma rays in treatment of advanced tumours of the head and neck. Report to the Medical Research Council

4 September 2023

8

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90532-7

The potential benefit from a perfect radiosensitizer and its dependence on reoxygenation

4 September 2023

10

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90532-7

Clinical testing of the radiosensitizer Ro 07-0582: experience with multiple doses

4 September 2023

11

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90532-7

Dose, time and fractionation: A clinical hypothesis

4 September 2023

12

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90532-7

A review of hypoxic cell radiosensitization in experimental tumors

4 September 2023

14

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90532-7

Optimum fractionation in X-ray treatment of C3H mouse mammary tumours

4 September 2023

15

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90532-7

Local control and site of failure in radically irradiated supraglottic laryngeal cancer.

4 September 2023

16

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90532-7

T3 glottic cancer: an analysis of dose time-volume factors

4 September 2023

17

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90532-7

Supraglottic laryngeal carcinoma: an analysis of dose-time-volume factors in 410 patients.

4 September 2023

18

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90532-7

Radiotherapy and hyperbaric oxygen in head and neck cancer. Final report of first controlled clinical trial

4 September 2023

19

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90532-7

The influence of the number of fractions, overall treatment time and field size on the local control of cancer of the skin

4 September 2023

20

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90532-7

The influence of the number of fractions and of overall treatment time on local control and late complication rate in squamous cell carcinoma of the larynx

4 September 2023

21

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90532-7

Carcinoma of the nasopharynx. Review of 146 patients with emphasis on radiation dose and time factors

4 September 2023

22

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90532-7

The results of treatment of cancer of the bladder—A clinical contribution to radiobiology

4 September 2023

23

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90532-7

Failure analysis of radical radiation therapy of supraglottic laryngeal carcinoma

4 September 2023

24

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90532-7

How can different prescribed doses give the same recurrence rate?

4 September 2023

25

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90532-7

A re-evaluation of split-course technique for squamous cell carcinoma of the head and neck

4 September 2023

26

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90532-7

Carcinoma of the tonsillar fossa. Significance of dose of irradiation and volume treated in the control of the primary tumor and metastatic neck nodes

4 September 2023

27

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90532-7

Dose-response relationship for supraglottic laryngeal carcinoma

4 September 2023

28

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90532-7

Tumor radioresistance in clinical radiotherapy

4 September 2023

29

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90532-7

A phase I study of the hypoxic cell radiosensitizer Ro-03-8799

4 September 2023

30

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90532-7

The clinical testing of Ro 03-8799--pharmacokinetics, toxicology, tissue and tumor concentrations

4 September 2023

31

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90532-7

Dose, time, volume relationships in squamous cell carcinoma of the supraglottic larynx

4 September 2023

33

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90532-7

The steepness of the dose response curve both for tumor cure and normal tissue injury

4 September 2023

34

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90532-7

The different clinical presentation, behaviour and prognosis of carcinomas originating in the epilarynx and the lower supraglottis.

4 September 2023

37

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90532-7

In vivo assessment of basic 2-nitroimidazole radiosensitizers

4 September 2023

38

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90532-7

The relationship of dose to prognosis in squamous-cell carcinoma of the aerodigestive tract.

4 September 2023

39

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90532-7

4 September 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6237084%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

1 reference